egfr modulates microrna maturation response hypoxia phosphorylation ago2
micrornas mirnas generated two-step processing yield small rnas negatively regulate target gene expression post-transcriptional level deregulation mirnas linked diverse pathological processes including cancer recent studies also implicated mirnas regulation cellular response spectrum stresses hypoxia frequently encountered poorly angiogenic core solid tumour however upstream regulators mirna biogenesis machineries remain obscure raising question tumour cells efficiently coordinate impose specificity mirna expression function response stresses show epidermal growth factor receptor egfr product well-characterized oncogene human cancers suppresses maturation specific tumour-suppressor-like mirnas response hypoxic stress phosphorylation argonaute ago2 tyr association egfr ago2 enhanced hypoxia leading elevated ago2-y393 phosphorylation turn reduces binding dicer ago2 inhibits mirna processing precursor mirnas mature mirnas also identify long-loop structure precursor mirnas critical regulatory element phospho-y393-ago2-mediated mirna maturation furthermore ago2-y393 phosphorylation mediates egfr-enhanced cell survival invasiveness hypoxia correlates poorer overall survival breast cancer patients study reveals previously unrecognized function egfr mirna maturation demonstrates egfr likely function regulator ago2 novel post-translational modification findings suggest modulation mirna biogenesis important stress response tumour cells potential clinical implications
